Opus Genetics, Inc.

IRD ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2011

Total Assets: $13.7M

Liabilities Breakdown FY2011

Total Liabilities: $3.0M